Discussion of aortic valve replacement has primarily concerned the choice between tissue and mechanical prostheses. Less emphasis has been placed on prosthesis size. Despite technical advances increasing prosthesis orifice area, small valves implanted in the unenlarged aortic root may not be significantly less obstructive than the stenotic native valves they replace. Methods: In this work we studied 52 patients (31 women, 21 men; mean age 59.2 years) in whom valve prostheses sized 19, 21, 23, or 25 mm (30 bioprostheses and 22 tilting disc valves) had been implanted to replace stenotic aortic valves. Most patients with 19 or 21 mm prostheses were women. Doppler and conventional echocardiographic studies were performed in the 10 days preceding the operation and between 10 and 40 months (mean 18 months) after the operation. The patients receiving larger valve sizes had significantly larger body surface areas than those receiving smaller valve sizes (mainly women). Results: No significant differences were observed between preoperative and postoperative diameters or left ventricular systolic function parameters, but left ventricular mass and mass index decreased in all four groups (albeit nonsignificantly in the 19 mm group, and with less statistical significance in the 21 mm group than in the 23 and 25 mm groups). Postoperative peak and mean transvalvular pressure drops were significantly greater in the 19 mm group than in the other groups, and the 21 mm group had significantly greater transvalvular pressure drops than the 25 mm group. Postoperative effective valve area was significantly smaller in the 19 mm group than in the 21 mm group, and significantly smaller in the 21 mm group than in the 23 and 25 mm groups. Conclusion: We conclude that despite undeniable recent improvements in the design of artificial heart valves, 19 mm aortic prostheses continue to create significant obstruction of the left ventricular outflow tract and, possibly as a consequence of this, fail to bring about significant reduction in left ventricular hypertrophy. (J Thorac Cardiovasc Surg 1996;112:273-80) 
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Patients and methods
Protocol. Between January 1989 and December 1994, 68 patients in our center underwent replacement of the aortic valve alone on account of predominantly aortic valvular stenosis. None of these patients underwent, or had previously undergone, a cardiovascular operation of any other kind. Thirty-seven other patients who were operated on for severe aortic stenosis in the same period were excluded from the study because they also had other types of cardiac disease: 18 had moderate or severe aortic insufficiency, 11 mitral valve disease, 5 coronary artery disease, 2 aortic insufficiency and coronary artery disease, and 1 mitral valve disease and coronary artery disease. The follow-up protocol of all 68 patients with "pure" aortic stenosis included evaluation of valve function by Doppler echocardiography. We studied retrospectively 52 of these patients who fulfilled the following criteria: (1) before the operation they had sinus rhythm and greater stenosis of a native aortic valve than of any other valve, and they had no other cardiac disease; (2) the operation consisted only in the implantation of an aortic valve prosthesis, with no aortic ring enlargement procedure; (3) a Doppler echocardiogram good enough for evaluation of left ventricular structure and function and aortic valve disease had been taken within the 10 days preceding the operation; and (4) 12 months or more after valve implantation the patients were in New York Heart Association (NYHA) functional classes I or II.
Of Of the 16 patients with "pure" aortic stenosis not included in the study, only two had 19 mm valve prostheses. One of these, who was in NYHA class III, died suddenly 33 days after the operation and the other was excluded from the study because of atrial fibrillation before the operation. One year after the operation, no patient with a 19 mm prosthesis was in NYHA class III or IV.
Echoeardiography. Echocardiograms were performed with a Hewlett-Packard Sonos 1000 apparatus (HewlettPackard Co., Palo Alto, Calif.) with 3.5 MHz transducers for images and 2.5 MHz transducers for Doppler effect measurements. All echocardiograms were recorded on SuperVHS videotape (Panasonic, Matsushita Electric Works, Osaka, Japan) for subsequent analysis.
M-mode measurements. M-mode echocardiograms were taken for measurement (in millimeters) of telediastolic interventricular septum thickness (IVST), left ventricular posterior wall thickness (PWT), and telediastolic (LVEDD) and telesystolic (LVESD) left ventricular diameters; simultaneous two-dimensional longitudinal or transverse parasternal views were used to ensure that the measurements were taken immediately above the papillary muscles. All measurements were repeated for four to six successive heartbeats, and the values accepted for each patient were the means of these four to six values.
LVM was calculated from Devereux and Reichek's formulal5: LVM (in grams) = 1.04 × ([LVEDD + IVST + PWT]) 3 -LVEDD 3) -13.6. LVM index (LVMI, in grams per square meter) was defined as LVM/BSA, where BSA is body surface area in square meters. Left ventricular fractional shortening (percent) was calculated as 100 × (LVEDD -LVESD)/ LVEDD. Left ventricular ejection fraction (percent) was calculated as 100 × (LVEDD 3 -LVESD3)/LVEDD 3.
Doppler effect measurements.
With the guidance of color flow images, systolic velocities in the outflow tract near the valve were measured in pulsed Doppler mode from the apical four-chamber view. Velocities through native and prosthetic aortic valves were measured in the continuous Doppler mode from apical, suprasternal, and right parasternal views; once the view giving the greatest velocities had been found, the velocities measured from this view during three cardiac cycles with durations close to the patienfs mean beat-to-beat interval were averaged to yield a single value for that patient. Pulsed Doppler mode was used to search for increased velocities within the left ventricle by stepping the sample volume from the apex to the valve.
Peak and mean systolic transvalvular pressure drops calculated from peak and mean flow velocities by the modified Bernoulli equation are in this article denoted PSG and MSG, respectively. PSGc denotes peak pressure drops calculated by means of the Bernoulli equation with correction for prevalvular velocities: PSGc = 4(Vvalv 2 -Vlvol2), where Vvalv is the peak velocity through the prosthesis and Vlvot the peak velocity in the left ventricular outflow tract just below the prosthesis. 16 The area (A) of the left ventricular outflow tract was calculated as p(D/2) 2, where D was the mean diameter of the tract in three successive images recorded at the beginning of systole from the longitudinal parasternal direction. Cardiac output (CO) was calculated as A × VTIlvot × HR, where HR is heart rate and VTIlvot is the time integral of the velocity in the left ventricular outflow tract. 17 Cardiac index was calculated as CO/BSA. Effective valve areas were calculated by means of both the standard continuity equation (VAstan = SV/VTIvalv, where SV is stroke volume and VTIvalv the time integra ! of the velocity through the valve) and the simplified equation (VAsimp = A × Vlvot/Vvalv). is ' 19 The effective area index, a measure of how well the flow area of the valve matches body size, was calculated as VAstan/BSA.
Intralaboratory variability.
To test intralaboratory variability in measurements of peak and mean gradients and effective valve areas, we repeated determinations of pulsed and continuous wave parameters and of left ventricular outflow tract diameter in 21 patients within 1 month of the postoperative echoeardiographic examination. Variability was expressed as mean percent error. percent error being calculated as the absolute difference between the two observations divided by the mean of the two and expressed as a percentage (Table I) .
Statistical analysis.
Results are expressed as means standard deviations. One-way analysis of variance was used to evaluate the significance of differences in measurements among valve sizes; if the F value was significant. the Tukey multiple comparison test was performed to assess differences between individual groups. Correlations between valve size and echocardiographic parameters were calculated by linear or second-degree polynomial regression analysis (or both) where appropriate. The significance of differences in the same group was estimated by means of Friedman's test. A probability (p) value less than 0.05 was considered statistically significant.
Results
Tables II and III list preoperative characteristics of the four groups of patients defined by the size of the aortic prosthesis implanted. The patients in the larger valve size groups had significantly larger body surface areas than those in the smaller valve size groups, and they were approximately equally distributed between the sexes, whereas most patients receiving 19 or 21 mm prostheses were women. There were no statistically significant differences among the size groups as regards heart rate, blood pressure, degree of stenosis, or overall left ventricular systolic function. LVM and LVMI were significantly smaller in the 19 mm group than in any of the others, but the latter did not differ significantly one from another. Table III negative correlations between valve size and peak and mean transvalvular pressure drops (r = -0.64 and r = -0.72, respectively; p < 0.001 in both cases). The prosthetic valve areas calculated from the simplified continuity equation correlated well with those given by the standard equation (VAsimp = 0.92 × VAstan + 0.12; r = 0.91, standard error of the estimate = 0.07). Postoperative effective valve area was significantly smaller in the 19 mm group than in the 21 mm group and significantly smaller in the 21 mm group than in the 23 and 25 mm groups, but there was no statistically significant difference between the latter two groups (Table IV and Fig. 2 ). There was good linear correlation between effective valve area and nominal valve size (r = 0.90, p < 0.001), and analysis of variance showed the four size groups to be better differentiated by effective valve area (F = 18.7 for VAstan, F = 19.6 for VAsimp; p < 0.001 in both cases) than by PSG (F = 6.56, p = 0.017) or MSG (F = 4.98, p = 0.039); but the effective area index also increased with valve size (r = 0.85, p < 0.001), showing valve prosthesispatient mismatch. In no prosthesis size group was there a significant difference between patients with mechanical prostheses and patients with bioprostheses as regards valve hemodynamics (PSG, MSG, or effective valve area).
Pandiastolic regurgitation was observed in apical continuous Doppler records in all 32 patients with mechanical prostheses and in 16 (53%) of those with bioprostheses (14 with Labcor-Santiago valves and 2 with MitroFlow valves). Peak regurgitation velocity was in all cases less than 1.7 m/sec, and it was significantly less for the bioprostheses than for the mechanical prostheses, 0.6 +_ 0.3 m/sec as against 1.3 _+ 0.3 m/sec (p < 0.01). Leakage penetrated 1 to 3 cm into the ventricle and was deemed slight or negligible. Color flow echocardiograms from apical (two-or four-chamber views) or long-axis parasternal views showed regurgitation jets in all 38 of these patients. The mechanical valves exhibited two lat- Valve size (mm) Although aortic transvalvular pressure drops are influenced by transvalvular flow rate, which should be taken into account in evaluating their clinical significance, they probably depend most on the diameter of the valve ring, increasing with decreasing ring size. In this study there was a significant negative correlation between valve size and peak and mean transvalvular pressure drops.
In a recent study, we TM found no significant difference between the hemodynamic performance of 19 mm pericardial bioprostheses and that of 19 mm bileaflet mechanical prostheses in the aortic position; as in other studies of the hemodynamics of small prostheses, 1 ' 22,22-24 in which effective valve areas of 0.9 to 1.2 cm 2 and mean PSGs as high as 40 mm Hg have been observed, transvalvular pressure drops and effective valve areas were far from satisfactory. These findings, together with recent reports that patients with small (19 or 21 ram) prostheses have a poorer prognosis than those with larger prostheses, 25 must be taken into account when planning operations for patients for whom aortic valve replacement is indicated.
In patients with aortic stenosis, left ventricular pressure is chronically elevated. LVH occurs as an adaptive response and, initially, keeps left ventricular stress (the force generated by each unit of myocardium) within the normal range. Hypertrophy can be quantitated by echocardiography. In relatively symmetric ventricles, without left ventricular aneurysm or diastolic shape abnormality caused by marked dilation of the right side of the heart (conditions shared by all the patients in this study), this can be done by means of measurements obtained in the: M modelS: echocardiographic estimates of LVM calculated from Devereux and Reichek's formula correlate well with angiographic estimates of LVM, with postmortem left ventricular weight, and with estimates obtained by applying Simpson's rule or an area-length formula to twodimensional echocardiographic measurements. New imaging techniques, such as nuclear magnetic resonance imaging and ultrafast computed tomography, provide images of the beating heart with high temporal and spatial resolution allowing more precise calculation of volumes and LVM, but echocardiography is still the most cost-efficient method.
The treatment of aortic stenosis by valve replacement is usually followed by the reduction of LVH by an amount variously reported as being between 16% and 44%. 26-29. Most regression occurs during the first 6 months after the operation. However, most studies of this phenomenon have involved patients with valves of size.. 21 mm or more; the available information on patients with 19 mm valves is scant. Sire and associates, 3° in a retrospective study of 39 of 714 patients in whom aortic valve prostheses of size 19, 21, or 23 mm had been implanted (accompanied by aortic ring enlargement in 168 cases), found that patients with a 19 mm aortic prosthesis and no other prostheses exhibited no significant reduction in LVM a mean of 26 months after the operation, whereas those with 21 or 23 mm prostheses did exhibit regression, and to similar extents. However, inasmuch as the 10 patients with 19 mm prostheses had preoperative LVMIs of 129 + 47 gm/m 2 (i.e., only slightly above normal, despite their having mean aortic pressure drops and valve areas suggestive of severe aortic stenosis), whereas the 21 and 23 mm groups had preoperative LVMIs of 150 gm/m 2 or more, Sire and coworkers 3° suggested that the surgeons in their institution might have chosen to implant 19 mm valves only in patients with no more than slight LVH. Certainly, the scant ventricular hypertrophy of Sim's 19 mm group, and the small size of the study (39 patients) in relation to the 714 patients in whom aortic valves had been implanted, oblige one to treat their findings with some reserve. Nevertheless, in our study we also found significant postoperative reduction in LVM in patients with 21 to 25 mm aortic prostheses but not in patients with 19 mm prostheses (despite the postoperative effective valve areas of the latter group having been, as in the study by Sim and associates, almost double their preoperative areas); although the 19 mm group had less severe LVH than the other groups, their preoperative LVMIs were far above the upper limit of the normal range (possibly because almost all the patients in this group were women).
The lack of a significant reduction in LVM in our 19 mm group may have been due to a number of factors: (1) regression of LVH being slower in these patients than in the recipients of larger valves (although all the patients with 19 mm prostheses had their follow-up examination more than 10 months after their operations); (2) this group being older than the others (age is an independent determinant of LVM31); and (3) the suboptimal hemodynamics of 19 mm prostheses at rest and during exercise. We are currently evaluating hemodynamics during exercise as part of a longer-term (3-to 5-year) study of patients with aortic valve prostheses implanted to replace stenotic native vanes. The failure of small aortic prostheses to reduce LVM may be related to the results of several studies showing their recipients to have a poorer prognosis than recipients of larger valves.
We conclude that despite undeniable recent improvements in the design of artificial heart valves, 19 mm aortic prostheses continue to create a significant obstruction of the left ventricular outflow tract and, possibly as a consequence of this, fail to bring about significant reduction in LVH. Aortic prostheses of this size should probably not be implanted in young or physically active patients or in patients with body surface areas greater than 1.7 m 2. Instead, aortic valve replacement in these groups of patients should probably be effected by means of a homograft or by implantation of a 21 mm or larger valve after aortic root enlargement.
